International society for antiviral research - 22nd international conference. Part 2.
Walker
Karen
K
Thomson Reuters, London, UK. karen.walker@thomsonreuters.com
D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D035843:Biomedical Research; D002986:Clinical Trials as Topic; D003333:Coronaviridae Infections / Q000188:drug therapy / Q000821:virology; D004353:Drug Evaluation, Preclinical; D015507:Drugs, Investigational / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy / Q000821:virology; D011213:Poxviridae Infections / Q000188:drug therapy / Q000821:virology
D000998:Antiviral Agents; D015507:Drugs, Investigational